ProShares Ultra NASDAQ Biotechnology
30 hedge funds and large institutions have $18.6M invested in ProShares Ultra NASDAQ Biotechnology in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
7
Closed
2
Calls
$7.58M
Puts
$6.62M
Net Calls
+$965K
Net Calls Change
+$3.71M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AF
26
Allworth Financial
Folsom,
California
| $3K | +$3K | +40 | New |
|
|
SFS
27
Sowell Financial Services
North Little Rock,
Arkansas
| $2K | +$2K | +23 | New |
|
|
CG
28
Cutler Group
San Francisco,
California
| $1K | -$3.85K | -100 | -79% |
|
|
SL
29
Savior LLC
Wellesley Hills,
Massachusetts
| $1K | +$91 | +1 | +10% |
|
30
Koshinski Asset Management
Decatur,
Illinois
| $388 | -$4 | -47 | -0.9% |
|
|
SW
31
SkyOak Wealth
Southfield,
Michigan
| – | -$690K | -9,500 | Closed |
|
|
S
32
SignatureFD
Atlanta,
Georgia
| – | -$22K | -300 | Closed |
|